|
Issue |
Title |
|
Vol 24, No 1 (2025) |
Effect of dapagliflozin on serum N‐terminal fragment-proB‐type natriuretic peptide level in patient with acute decompensated heart failure |
Abstract
PDF (Eng)
|
Hanna Jassim Dohei, Maitham Ali Al-Rikabi |
|
Vol 24, No 1 (2025) |
The role of free nucleotides in heart failure |
Abstract
PDF (Rus)
|
E. V. Kolesnikova, O. V. Myachina, A. N. Pashkov, A. A. Pashkova |
|
Vol 23, No 6 (2024) |
Interaction of serum heat shock proteins’ levels with the severity of venous congestion in patients with acute decompensated heart failure with preserved ejection fraction |
Abstract
PDF (Rus)
|
Yu. S. Timofeev, A. R. Afaunova, A. A. Ivanova, T. Yu. Vedenikin, O. N. Dzhioeva, V. A. Metelskaya, M. S. Pokrovskaya, O. M. Drapkina |
|
Vol 23, No 4 (2024) |
Left atrial stiffness index in the identification of heart failure with preserved ejection fraction |
Abstract
PDF (Rus)
|
N. E. Shirokov, E. I. Yaroslavskaya, M. D. Kosterin, D. V. Krinochkin, E. A. Gorbatenko, T. N. Enina, N. A. Musikhina |
|
Vol 23, No 3 (2024) |
The role of Pseudomonas aeruginosa pneumonia in the development of cardiovascular events in patients with heart failure |
Abstract
PDF (Rus)
|
V. I. Podzolkov, A. I. Tarzimanova, L. A. Ponomareva, A. A. Ivannikov, A. A. Chinova, E. N. Popova, A. B. Ponomarev, O. A. Morozova, L. G. Gladun, A. Yu. Isaeva |
|
Vol 23, No 2 (2024) |
Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction |
Abstract
PDF (Rus)
|
K. N. Vitt, E. A. Kuzheleva, O. V. Tukish, M. V. Soldatenko, M. Yu. Kondratiev, O. N. Ogurkova, T. E. Suslova, A. A. Garganeeva |
|
Vol 22, No 12 (2023) |
Gut microbiota at different stages of cardiovascular disease continuum |
Abstract
PDF (Rus)
|
A. A. Yafarova, E. D. Dementyeva, O. A. Zlobovskaya, A. R. Kiselev, A. F. Sheptulina, G. A. Ashniev, L. M. Zhamalov, V. V. Makarov, S. M. Yudin, O. M. Drapkina |
|
Vol 21, No 7 (2022) |
Factors associated with the intermediate probability of heart failure with preserved ejection fraction on the H2FPEF score in asymptomatic patients in rotation work conditions in the Arctic |
Abstract
PDF (Rus)
|
A. S. Vetoshkin, N. P. Shurkevich, A. A. Simonyan, L. I. Gapon, M. A. Kareva |
|
Vol 21, No 7 (2022) |
Prognostic value of hypoxia-inducible factor-1 alpha gene polymorphism in patients with heart failure with preserved ejection fraction and obstructive sleep apnea |
Abstract
PDF (Rus)
|
A. V. Yakovlev, R. S. Chernyshev, K. S. Sakhonchik, S. N. Shilov, E. V. Grakova, K. V. Kop’eva, A. T. Teplyakov, I. A. Efremov, M. S. Kessler, N. F. Yakovleva, I. A. Grebenkina |
|
Vol 20, No 2 (2021) |
Relationship between plasma aldosterone and left ventricular structure and function in patients with heart failure with preserved ejection fraction |
Abstract
PDF (Rus)
|
A. N. Shevelok |
|
Vol 19, No 5 (2020) |
Fluid retention in patients with paroxysmal and permanent atrial fibrillation and heart failure |
Abstract
PDF (Rus)
|
V. V. Kirillova, L. A. Sokolova, A. A. Garganeyeva, V. N. Meshchaninov, R. E. Batalov |
|
Vol 19, No 5 (2020) |
Left ventricular global function index: prognostic value in patients with heart failure aged 60 years and older |
Abstract
PDF (Rus)
|
V. N. Larina, V. I. Lunev, M. N. Alekhin |
|
Vol 19, No 3 (2020) |
Analysis of the relationship between systemic inflammation and diastolic dysfunction in patients with heart failure and rheumatoid arthritis |
Abstract
PDF (Rus)
|
A. S. Ankudinov, A. N. Kalyagin |
|
Vol 14, No 3 (2015) |
AN EXPERIENCE OF SERELAXINE USE FOR ACUTE HEART FAILURE IN PATIENTS WITH ONCOHEMATOLOGICAL DISEASES |
Abstract
PDF (Rus)
|
L. A. Shpagina, L. A. Panacheva, E. M. Loctin, O. S. Pospelova, V. N. Kotova, V. N. Kokhno, А. А. Rukavitsina |
|
Vol 13, No 5 (2014) |
COMPARISON STUDY OF BIOGENIC STIMULATORS INFLUENCE ON REACTIVE OXYGEN SPECIES FORMATION BY BLOOD PHAGOCYTES IN PATIENTS WITH HEART FAILURE IN VITRO |
Abstract
PDF (Rus)
|
E. I. Astashkin, M. P. Kruglova, M. G. Glezer, N. S. Orekhova, A. N. Novikova, S. V. Grachev |
|
Vol 11, No 1 (2012) |
Taurine effects on the occurrence of cardiac arrhythmias and QT interval dispersion in patients with postinfarction cardiosclerosis and chronic heart failure: a comparative randomised study |
Abstract
PDF (Rus)
|
I. G. Gordeev, E. M. Pokrovskaya, E. E. Luchinkina |
|
Vol 11, No 1 (2012) |
Oral health and heart failure |
Abstract
PDF (Rus)
|
I. V. Vashurin, V. D. Wagner, K. G. Gurevich, M. V. Gurevich |
|
Vol 11, No 1 (2012) |
Effects of transluminal balloon angioplasty and stenting on the clinical course of ischemic chronic heart failure with preserved or reduced left ventricular ejection fraction: radionuclide 4D tomoventriculography data |
Abstract
PDF (Rus)
|
N. V. Shashkova, S. N. Tereshchenko, L. E. Samoylenko, D. F. Satlykova, A. M. Gerasimov |
|
Vol 10, No 4 (2011) |
β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure |
Abstract
PDF (Rus)
|
G. Ambrosio, M. D. Flather, M. Böhm, A. J.S. Coats, L. Tavazzi, D. J. van Veldhuisen, M. G. Conti, G. Spinucci, F. Mascagni, A. Murrone, A. Cohen-Solal |
|
Vol 9, No 3 (2010) |
Health School effectiveness in patients with chronic heart failure: gender differences |
Abstract
PDF (Rus)
|
M. V. Malishevsky, A. P. Potapov, N. E. Zol’nikova, P. N. Zhvavy, G. A. Kostolomova, N. Ya. Utusikova, Yu. A. Ippolitova, T. V. Klevtsova, V. A. Sharipov, S. D. Chesalina |
|
Vol 9, No 3 (2010) |
Trimetazidine MB treatment in patients with chronic heart failure |
Abstract
PDF (Rus)
|
T. E. Morozova, E. I. Ivanova |
|
Vol 9, No 3 (2010) |
Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction |
Abstract
PDF (Rus)
|
S. A. Sayganov, Yu. N. Grishkin |
|
Vol 7, No 4 (2008) |
Selective beta-blocker bisoprolol: effectiveness and safety in complex treatment of patients with chronic heart failure and Type 2 diabetes mellitus. RAMBO-DM CHF Study results |
Abstract
PDF (Rus)
|
Yu. V. Lapina, A. A. Petrukhina, O. Yu. Narusov, V. Yu. Mareev, M. G. Bolotina, M. V. Shestakova, V. P. Masenko, G. N. Litonova, N. A. Baklanova, Yu. N. Belenkov |
|
Vol 7, No 4 (2008) |
Prognostic value of renal function in patients with acute decompensation of chronic heart failure |
Abstract
PDF (Rus)
|
I. A. Meray, A. Yu. Yurovsky, E. P. Pavlikova, M. A. Efremovtseva, V. S. Moiseev |
|
Vol 7, No 4 (2008) |
Target organs in patients with post-infarction chronic heart failure: dynamics during complex therapy including beta-adrenoblockers |
Abstract
PDF (Rus)
|
I. P. Rubesh, L. A. Nekrutenko, A. V. Tuev, Yu. V. Larina, A. V. Agafonov |
|
Vol 7, No 4 (2008) |
Chronic heart failure in out-patient practice: aetiology issues |
Abstract
PDF (Rus)
|
S. M. Bogdanova, N. V. Makarova |
|
Vol 10, No 7 (2011) |
Myocardial revascularization results: electrical, structural, and geometric left ventricular remodelling in diastolic heart failure |
Abstract
PDF (Rus)
|
I. P. Tatarchenko, N. V. Pozdnyakova, I. A. Petrushin, O. I. Morozova, A. G. Mordovina |
|
Vol 10, No 7 (2011) |
Intima-media thickness and large artery elasticity in patients with ischemic chronic heart failure |
Abstract
PDF (Rus)
|
N. A. Kosheleva, A. P. Rebrov, O. V. Karpova, T. V. Martynova |
|
Vol 9, No 7 (2010) |
Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome |
Abstract
PDF (Rus)
|
I. V. Kryuchkova, A. S. Adamchik |
|
Vol 5, No 8 (2006) |
Trimetazidine in chronic heart failure patients aged above 75 years |
Abstract
PDF (Rus)
|
I. V. Ignatenko, A. L. Pirogov, D. A. Altman, A. S. Prazdnov, N. K. Vereina |
|
Vol 5, No 7 (2006) |
Intraventricular septum role in chronic heart failure pathogenesis |
Abstract
PDF (Rus)
|
N. A. Galanina, I. G. Fomina, Z. O. Georgadze, V. V. Matveev, N. E. Gaidamakina, N. B. Kinyasheva |
|
1 - 31 of 31 Items |
|